Psilacetin

Next-generation R&D psychedelics company Psilera Inc. shared its two proprietary DMT analogs PSIL-001 and PSIL-002’s preclinical positive results for mental health disorder treatments.  Psilera uses machine-learning methods to map complex datasets and identify early-stage lead...